A single view of all the companies in the same space to infer if the stock is undervalued, overvalued or priced right. This would be one way to analyze a longer terms investment in a particular sector.
| Company | Market Cap | Income | Sales | P/E | P/B | Cash/Share | Dividend | Dividend Yield | Price To Cash Ratio | Debt to Equity Ratio | ROE | ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics plc | 326,670,000 | -158,100,000 | 6,100,000 | 0.00 | 1.48 | 2.22 | - | - | 0.88 | 0.00 | -61.20% | -38.90% |
| Abcam plc | 4,190,000,000 | 5,100,000 | 410,900,000 | 781.82 | 4.57 | 0.51 | - | - | 33.80 | 0.35 | 0.60% | 0.50% |
| Acumen Pharmaceuticals, Inc. | 167,040,000 | -100,600,000 | 330,000 | 0.00 | 0.38 | 4.92 | - | - | 0.86 | 0.00 | -131.10% | -69.30% |
| Achilles Therapeutics plc | 101,010,000 | -61,100,000 | 0 | 0.00 | 0.33 | 6.54 | - | - | 0.38 | 0.00 | -22.30% | -20.30% |
| Acorda Therapeutics, Inc. | 20,450,000 | -104,000,000 | 129,100,000 | 0.00 | 0.11 | 0.00 | - | - | 0.00 | 1.18 | -58.40% | -20.80% |
| Adagio Therapeutics, Inc. | 363,000,000 | -226,800,000 | 0 | 0.00 | 0.60 | 5.00 | - | - | 0.61 | 0.00 | -96.20% | -50.40% |
| ADMA Biologics, Inc. | 403,400,000 | -71,600,000 | 80,900,000 | 0.00 | 2.53 | 0.25 | - | - | 7.89 | 0.67 | -61.20% | -29.10% |
| Adaptive Biotechnologies Corporation | 1,440,000,000 | -207,300,000 | 154,300,000 | 0.00 | 2.18 | 2.29 | - | - | 4.08 | 0.00 | -31.00% | -20.60% |
| Agenus Inc. | 597,740,000 | -24,100,000 | 295,700,000 | 0.00 | 16.38 | 1.09 | - | - | 1.95 | 0.39 | 26.80% | -7.30% |
| Applied Genetic Technologies Corporation | 52,360,000 | -63,300,000 | 500,000 | 0.00 | 0.82 | 1.38 | - | - | 0.72 | 0.39 | -83.30% | -55.10% |
| Alector, Inc. | 938,490,000 | -36,300,000 | 207,100,000 | 0.00 | 2.88 | 8.32 | - | - | 1.28 | 0.00 | -13.90% | -5.80% |
| Aligos Therapeutics, Inc. | 63,150,000 | -128,300,000 | 4,400,000 | 0.00 | 0.32 | 4.20 | - | - | 0.33 | 0.00 | -67.00% | -54.30% |
| Allogene Therapeutics, Inc. | 1,200,000,000 | -257,000,000 | 38,500,000 | 0.00 | 1.26 | 3.15 | - | - | 2.63 | 0.00 | -25.80% | -23.20% |
| AlloVir, Inc. | 447,380,000 | -172,000,000 | 0 | 0.00 | 1.39 | 2.75 | - | - | 1.80 | 0.00 | -61.10% | -53.70% |
| Ambrx Biopharma Inc. | 151,250,000 | 0 | 12,320,000 | 0.00 | 0.67 | 4.07 | - | - | 0.90 | 0.00 | - | - |
| Aptose Biosciences Inc. | 108,630,000 | -65,400,000 | 0 | 0.00 | 1.40 | 0.84 | - | - | 1.37 | 0.00 | -70.60% | -65.20% |
| argenx SE | 17,780,000,000 | -408,300,000 | 497,300,000 | 0.00 | 6.50 | 42.02 | - | - | 7.61 | 0.00 | - | - |
| Armata Pharmaceuticals Inc. | 152,610,000 | -23,200,000 | 4,500,000 | 0.00 | 4.87 | 0.32 | - | - | 14.82 | 0.00 | -82.90% | -43.40% |
| Athira Pharma, Inc. | 436,050,000 | -54,900,000 | 0 | 0.00 | 1.59 | 6.63 | - | - | 1.72 | 0.00 | -16.00% | -15.60% |
| Atara Biotherapeutics, Inc. | 723,610,000 | -340,100,000 | 20,300,000 | 0.00 | 2.54 | 3.74 | - | - | 1.95 | 0.00 | -103.00% | -71.40% |
| Autolus Therapeutics plc | 343,340,000 | -142,100,000 | 2,300,000 | 0.00 | 0.92 | 3.18 | - | - | 1.11 | 0.00 | -49.80% | -41.10% |
| AVROBIO, Inc. | 48,100,000 | -119,100,000 | 0 | 0.00 | 0.27 | 4.10 | - | - | 0.25 | 0.09 | -58.30% | -52.70% |
| Anavex Life Sciences Corp. | 806,380,000 | -40,900,000 | 0 | 0.00 | 5.01 | 1.81 | - | - | 5.34 | 0.00 | -30.90% | -28.80% |
| Axcella Health Inc. | 111,890,000 | -64,599,999 | 0 | 0.00 | 3.33 | 0.94 | - | - | 2.03 | 0.00 | -154.50% | -85.50% |
| Ayala Pharmaceuticals, Inc. | 39,350,000 | -40,300,000 | 3,500,000 | 0.00 | 1.20 | 2.53 | - | - | 1.06 | 0.00 | -95.10% | -82.80% |
| BioAtla, Inc. | 148,890,000 | -95,400,000 | 300,000 | 0.00 | 0.65 | 6.07 | - | - | 0.61 | 0.00 | -46.80% | -39.00% |
| BioCardia, Inc. | 29,050,000 | -12,600,000 | 1,000,000 | 0.00 | 2.84 | 0.77 | - | - | 2.25 | 0.00 | -87.00% | -65.90% |
| Brainstorm Cell Therapeutics Inc. | 110,920,000 | -24,500,000 | 0 | 0.00 | 5.77 | 0.61 | - | - | 5.02 | 0.00 | -88.40% | -63.30% |
| BioCryst Pharmaceuticals, Inc. | 1,980,000,000 | -184,100,000 | 157,200,000 | 0.00 | 0.00 | 2.58 | - | - | 3.91 | 0.00 | 169.20% | -52.00% |
| Black Diamond Therapeutics, Inc. | 112,940,000 | -125,600,000 | 0 | 0.00 | 0.51 | 5.11 | - | - | 0.54 | 0.00 | -53.10% | -44.70% |
| Beam Therapeutics Inc. | 3,160,000,000 | -370,600,000 | 51,800,000 | 0.00 | 3.64 | 13.53 | - | - | 3.27 | 0.01 | -55.90% | -35.20% |
| bluebird bio, Inc. | 319,260,000 | -562,600,000 | 3,700,000 | 0.00 | 0.76 | 3.87 | - | - | 1.07 | 0.00 | -95.60% | -65.20% |
| BioNTech SE | 40,500,000,000 | 11,150,000,000 | 20,560,000,000 | 3.53 | 2.94 | 8.61 | - | - | 18.02 | 0.03 | 143.90% | 94.80% |
| Cabaletta Bio, Inc. | 50,550,000 | -46,300,000 | 0 | 0.00 | 0.38 | 3.84 | - | - | 0.41 | 0.00 | -42.20% | -40.00% |
| Candel Therapeutics, Inc. | 157,840,000 | -36,100,000 | 100,000 | 0.00 | 2.17 | 2.53 | - | - | 1.91 | 0.01 | -256.00% | -57.60% |
| C4 Therapeutics, Inc. | 447,680,000 | -83,900,000 | 45,800,000 | 0.00 | 1.17 | 6.46 | - | - | 1.45 | 0.03 | -22.90% | -17.50% |
| Codiak BioSciences, Inc. | 94,720,000 | -37,200,000 | 22,900,000 | 0.00 | 1.55 | 0.00 | - | - | 0.00 | 0.47 | -71.40% | -21.30% |
| Creative Medical Technology Holdings, Inc. | 16,079,999 | 19,200,000 | 40,000 | 0.27 | 0.75 | 1.46 | - | - | 1.50 | 0.00 | - | 480.20% |
| Cullinan Oncology, Inc. | 515,169,999 | -65,599,999 | 18,900,000 | 0.00 | 1.11 | 6.26 | - | - | 1.77 | 0.00 | -14.60% | -14.30% |
| Compugen Ltd. | 224,120,000 | -34,200,000 | 6,000,000 | 0.00 | 1.98 | 1.29 | - | - | 1.92 | 0.00 | -32.60% | -27.00% |
| Coherus BioSciences, Inc. | 781,820,000 | -287,100,000 | 326,600,000 | 0.00 | 7.57 | 0.00 | - | - | 0.00 | 4.19 | -224.10% | -40.20% |
| Cellectis S.A. | 184,450,000 | -114,200,000 | 67,099,999 | 0.00 | 0.78 | 3.83 | - | - | 0.99 | 0.45 | - | - |
| Checkmate Pharmaceuticals, Inc. | 224,520,000 | -61,400,000 | 0 | 0.00 | 3.23 | 3.28 | - | - | 3.17 | 0.00 | -68.50% | -63.00% |
| Compass Therapeutics, Inc. | 152,840,000 | -82,200,000 | 0 | 0.00 | 0.92 | 1.41 | - | - | 1.06 | 0.00 | -145.30% | -118.40% |
| Caribou Biosciences, Inc. | 506,330,000 | -66,900,000 | 9,600,000 | 0.00 | 1.24 | 5.89 | - | - | 1.35 | 0.00 | -37.80% | -21.80% |
| Cardiff Oncology, Inc. | 70,690,000 | -28,300,000 | 400,000 | 0.00 | 0.44 | 3.05 | - | - | 0.50 | 0.00 | -21.10% | -20.10% |
| Curis, Inc. | 111,070,000 | -45,400,000 | 10,600,000 | 0.00 | 1.13 | 1.17 | - | - | 0.96 | 0.00 | -42.50% | -25.70% |
| CRISPR Therapeutics AG | 4,560,000,000 | 377,700,000 | 915,000,000 | 12.96 | 1.83 | 29.85 | - | - | 1.92 | 0.00 | 16.20% | 14.50% |
| Cortexyme, Inc. | 129,500,000 | -89,900,000 | 0 | 0.00 | 0.99 | 3.22 | - | - | 1.21 | 0.00 | -65.40% | -58.40% |
| Champions Oncology, Inc. | 103,620,000 | 400,000 | 46,800,000 | 254.33 | 11.22 | 0.64 | - | - | 11.91 | 0.00 | 5.40% | 1.50% |
| CEL-SCI Corporation | 156,360,000 | -37,500,000 | 0 | 0.00 | 2.42 | 0.68 | - | - | 4.21 | 0.26 | -76.10% | -54.80% |
| DBV Technologies S.A. | 157,250,000 | -97,800,000 | 5,700,000 | 0.00 | 1.52 | 0.67 | - | - | 2.03 | 0.00 | -74.00% | -52.90% |
| Ginkgo Bioworks Holdings, Inc. | 6,110,000,000 | -1,830,000,000 | 313,800,000 | 0.00 | 3.96 | 0.98 | - | - | 3.94 | 0.01 | -119.90% | -95.40% |
| Denali Therapeutics Inc. | 3,520,000,000 | -290,600,000 | 48,700,000 | 0.00 | 3.44 | 6.66 | - | - | 4.07 | 0.00 | -28.00% | -19.70% |
| Precision BioSciences, Inc. | 154,790,000 | -30,600,000 | 115,500,000 | 0.00 | 1.57 | 2.19 | - | - | 1.08 | 0.00 | -34.80% | -13.10% |
| Dyadic International, Inc. | 66,099,999 | -13,100,000 | 2,400,000 | 0.00 | 3.69 | 0.73 | - | - | 3.27 | 0.00 | -58.70% | -52.30% |
| Editas Medicine, Inc. | 1,080,000,000 | -192,500,000 | 25,500,000 | 0.00 | 1.85 | 6.92 | - | - | 2.16 | 0.00 | -32.20% | -26.30% |
| Eiger BioPharmaceuticals, Inc. | 230,460,000 | -33,900,000 | 12,100,000 | 0.00 | 3.11 | 2.55 | - | - | 2.60 | 0.44 | -34.20% | -22.60% |
| Elevation Oncology, Inc. | 60,290,000 | -32,000,000 | 0 | 0.00 | 0.21 | 5.90 | - | - | 0.41 | 0.00 | -30.70% | -23.80% |
| Entera Bio Ltd. | 85,970,000 | -12,200,000 | 600,000 | 0.00 | 3.17 | 0.79 | - | - | 3.45 | 0.00 | -59.80% | -47.50% |
| ERYTECH Pharma S.A. | 56,730,000 | -71,800,000 | 4,500,000 | 0.00 | 0.98 | 1.50 | - | - | 1.12 | 0.57 | - | - |
| Evaxion Biotech A/S | 67,660,000 | -24,500,000 | 0 | 0.00 | 1.84 | 1.46 | - | - | 2.10 | 0.11 | -99.40% | -77.40% |
| Exelixis, Inc. | 7,500,000,000 | 231,100,000 | 1,440,000,000 | 31.90 | 3.28 | 4.47 | - | - | 5.11 | 0.00 | 11.20% | 9.60% |
| Fate Therapeutics, Inc. | 3,610,000,000 | -212,200,000 | 55,800,000 | 0.00 | 5.00 | 6.04 | - | - | 5.87 | 0.00 | -28.80% | -21.40% |
| Fennec Pharmaceuticals Inc. | 157,940,000 | -17,300,000 | 170,000 | 0.00 | 9.77 | 0.80 | - | - | 7.49 | 0.32 | -84.60% | -66.50% |
| Forma Therapeutics Holdings, Inc. | 410,090,000 | -173,000,000 | 0 | 0.00 | 0.79 | 9.43 | - | - | 0.88 | 0.00 | -30.90% | -28.50% |
| Finch Therapeutics Group, Inc. | 151,780,000 | -58,200,000 | 18,500,000 | 0.00 | 0.60 | 2.26 | - | - | 1.14 | 0.00 | -26.10% | -23.90% |
| Freeline Therapeutics Holdings plc | 56,940,000 | -140,400,000 | 0 | 0.00 | 0.27 | 1.89 | - | - | 0.48 | 0.00 | -82.80% | -75.10% |
| Fusion Pharmaceuticals Inc. | 262,459,999 | -81,000,000 | 1,400,000 | 0.00 | 1.10 | 4.52 | - | - | 1.31 | 0.00 | -31.80% | -29.50% |
| Monte Rosa Therapeutics, Inc. | 636,590,000 | -74,000,000 | 0 | 0.00 | 0.92 | 6.99 | - | - | 1.84 | 0.00 | -29.20% | -22.80% |
| Gamida Cell Ltd. | 188,320,000 | -89,800,000 | 0 | 0.00 | 3.81 | 1.44 | - | - | 1.96 | 1.63 | -151.00% | -50.80% |
| Genocea Biosciences, Inc. | 23,500,000 | -33,200,000 | 1,600,000 | 0.00 | 0.96 | 0.59 | - | - | 0.63 | 0.32 | -187.80% | -47.10% |
| Genfit SA | 193,420,000 | 72,900,000 | 92,700,000 | 2.99 | 5.23 | 1.91 | - | - | 1.95 | 0.00 | - | - |
| Graphite Bio, Inc. | 247,660,000 | -70,800,000 | 0 | 0.00 | 0.60 | 6.50 | - | - | 0.66 | 0.00 | -26.20% | -20.40% |
| Gritstone bio, Inc. | 237,640,000 | -75,100,000 | 48,200,000 | 0.00 | 1.11 | 2.58 | - | - | 1.18 | 0.00 | -37.40% | -29.40% |
| Halozyme Therapeutics, Inc. | 6,120,000,000 | 402,700,000 | 443,300,000 | 16.24 | 31.64 | 5.40 | - | - | 8.25 | 4.45 | 241.90% | 37.60% |
| Harpoon Therapeutics, Inc. | 96,120,000 | -116,700,000 | 23,700,000 | 0.00 | 1.53 | 3.82 | - | - | 0.71 | 0.00 | -142.20% | -59.30% |
| Humacyte, Inc. | 871,190,000 | -26,500,000 | 1,300,000 | 0.00 | 6.47 | 1.98 | - | - | 3.86 | 0.41 | -29.00% | -13.40% |
| ImmunityBio, Inc. | 1,990,000,000 | -346,800,000 | 900,000 | 0.00 | 0.00 | 0.67 | - | - | 6.28 | 0.00 | 179.10% | -121.80% |
| Icosavax, Inc. | 402,160,000 | -67,000,000 | 7,800,000 | 0.00 | 1.29 | 6.34 | - | - | 1.44 | 0.00 | -53.70% | -32.20% |
| Ikena Oncology, Inc. | 219,740,000 | -34,100,000 | 31,000,000 | 0.00 | 1.02 | 6.21 | - | - | 0.95 | 0.00 | -16.00% | -12.60% |
| Inhibikase Therapeutics, Inc. | 31,100,000 | -14,800,000 | 3,100,000 | 0.00 | 0.80 | 1.59 | - | - | 0.76 | 0.01 | -43.30% | -39.60% |
| Immunocore Holdings plc | 1,500,000,000 | -171,300,000 | 34,600,000 | 0.00 | 6.96 | 7.31 | - | - | 4.86 | 0.37 | -62.50% | -38.50% |
| Immatics N.V. | 545,270,000 | -101,100,000 | 37,700,000 | 0.00 | 19.93 | 2.36 | - | - | 3.47 | 0.41 | -162.80% | -45.10% |
| Immunovant, Inc. | 581,150,000 | -137,700,000 | 0 | 0.00 | 1.10 | 4.38 | - | - | 1.10 | 0.00 | -30.60% | -28.80% |
| IN8bio, Inc. | 61,940,000 | -14,700,000 | 0 | 0.00 | 1.76 | 2.13 | - | - | 1.67 | 0.02 | -141.60% | -46.00% |
| Inhibrx, Inc. | 684,000,000 | -81,800,000 | 7,200,000 | 0.00 | 11.93 | 3.11 | - | - | 5.21 | 0.00 | -176.30% | -59.90% |
| INmune Bio, Inc. | 155,140,000 | -30,300,000 | 200,000 | 0.00 | 1.77 | 3.84 | - | - | 2.07 | 0.18 | -44.10% | -36.30% |
| Iovance Biotherapeutics, Inc. | 2,770,000,000 | -342,300,000 | 0 | 0.00 | 4.26 | 3.07 | - | - | 5.50 | 0.00 | -50.50% | -42.70% |
| Innate Pharma S.A. | 239,170,000 | -49,300,000 | 13,100,000 | 0.00 | 2.06 | 1.62 | - | - | 1.84 | 0.79 | - | - |
| Century Therapeutics, Inc. | 721,190,000 | -95,800,000 | 0 | 0.00 | 1.73 | 3.84 | - | - | 3.24 | 0.02 | -32.60% | -22.70% |
| iTeos Therapeutics, Inc. | 1,130,000,000 | 214,500,000 | 344,800,000 | 5.42 | 1.91 | 22.47 | - | - | 1.33 | 0.00 | 56.20% | 34.90% |
| Jounce Therapeutics, Inc. | 372,490,000 | -90,900,000 | 26,900,000 | 0.00 | 1.54 | 3.22 | - | - | 2.09 | 0.00 | -35.20% | -31.80% |
| Jasper Therapeutics, Inc. | 113,160,000 | -30,600,000 | 0 | 0.00 | 1.43 | 2.05 | - | - | 1.34 | 0.00 | -37.80% | -30.50% |
| Kodiak Sciences Inc. | 347,870,000 | -267,000,000 | 0 | 0.00 | 0.49 | 13.27 | - | - | 0.48 | 0.00 | -35.70% | -27.40% |
| Kiromic BioPharma, Inc. | 10,840,000 | -25,800,000 | 0 | 0.00 | 0.36 | 1.47 | - | - | 0.43 | 0.02 | -132.10% | -119.70% |
| Krystal Biotech, Inc. | 1,830,000,000 | -69,600,000 | 0 | 0.00 | 2.72 | 16.70 | - | - | 4.18 | 0.00 | -15.00% | -14.20% |
| Kymera Therapeutics, Inc. | 1,950,000,000 | -100,200,000 | 72,800,000 | 0.00 | 3.86 | 7.84 | - | - | 4.40 | 0.00 | -27.20% | -18.70% |
| Lineage Cell Therapeutics, Inc. | 241,070,000 | -43,000,000 | 4,300,000 | 0.00 | 2.40 | 0.32 | - | - | 4.14 | 0.00 | -37.80% | -30.30% |
| aTyr Pharma, Inc. | 127,880,000 | -33,800,000 | 2,049,999 | 0.00 | 1.11 | 3.68 | - | - | 1.19 | 0.00 | -42.50% | -39.30% |
| La Jolla Pharmaceutical Company | 105,870,000 | 19,700,000 | 75,700,000 | 7.25 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | -27.10% | 20.10% |
| LogicBio Therapeutics, Inc. | 18,880,000 | -40,000,000 | 5,400,000 | 0.00 | 0.58 | 1.53 | - | - | 0.35 | 0.27 | -95.00% | -56.60% |
| Mesoblast Limited | 551,460,000 | -97,200,000 | 9,900,000 | 0.00 | 0.96 | 0.68 | - | - | 5.84 | 0.19 | -17.10% | -13.20% |
| MeiraGTx Holdings plc | 588,660,000 | -79,600,000 | 37,700,000 | 0.00 | 3.07 | 3.01 | - | - | 4.27 | 0.00 | -39.80% | -24.70% |
| Miromatrix Medical Inc. | 71,530,000 | -14,700,000 | 40,000 | 0.00 | 1.32 | 2.59 | - | - | 1.35 | 0.01 | -46.80% | -29.70% |
| Molecular Partners AG | 552,390,000 | -66,900,000 | 10,200,000 | 0.00 | 4.76 | 4.18 | - | - | 3.97 | 0.06 | - | - |
| Neurocrine Biosciences, Inc. | 9,390,000,000 | 89,600,000 | 1,130,000,000 | 102.69 | 6.48 | 7.11 | - | - | 13.19 | 0.00 | 6.90% | 4.50% |
| NanoString Technologies, Inc. | 1,010,000,000 | -115,300,000 | 145,100,000 | 0.00 | 5.28 | 7.09 | - | - | 2.89 | 1.27 | -55.40% | -23.00% |
| Novavax, Inc. | 4,410,000,000 | -1,743,800,000 | 1,150,000,000 | 0.00 | 0.00 | 17.26 | - | - | 2.91 | 0.00 | -368.20% | -66.40% |
| Ocugen, Inc. | 599,540,000 | -58,400,000 | 0 | 0.00 | 5.17 | 0.39 | - | - | 6.31 | 0.02 | -63.80% | -58.30% |
| Omega Therapeutics, Inc. | 227,410,000 | -56,900,000 | 0 | 0.00 | 0.64 | 4.50 | - | - | 0.97 | 0.05 | - | - |
| Opthea Limited | 250,530,000 | 0 | 100,000 | 0.00 | 1.85 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Orchard Therapeutics plc | 88,700,000 | -144,600,000 | 1,700,000 | 0.00 | 0.40 | 1.65 | - | - | 0.40 | 0.16 | -57.20% | -40.40% |
| Outlook Therapeutics, Inc. | 401,100,000 | -53,200,000 | 0 | 0.00 | 6.42 | 0.29 | - | - | 5.71 | 0.46 | -244.90% | -118.50% |
| Oyster Point Pharma, Inc. | 209,380,000 | -100,700,000 | 24,500,000 | 0.00 | 1.91 | 6.71 | - | - | 1.08 | 0.90 | -72.00% | -52.70% |
| Vaxcyte, Inc. | 1,350,000,000 | -100,100,000 | 0 | 0.00 | 4.80 | 4.69 | - | - | 5.50 | 0.00 | -32.40% | -28.20% |
| PharmaCyte Biotech, Inc. | 42,890,000 | -3,800,000 | 0 | 0.00 | 0.51 | 4.34 | - | - | 0.50 | 0.00 | -7.70% | -7.60% |
| Pluristem Therapeutics Inc. | 59,960,000 | -51,200,000 | 0 | 0.00 | 1.40 | 1.69 | - | - | 1.03 | 0.58 | -95.70% | -60.60% |
| Poseida Therapeutics, Inc. | 204,620,000 | -125,000,000 | 31,200,000 | 0.00 | 1.27 | 3.20 | - | - | 0.99 | 0.00 | -69.40% | -43.00% |
| Renovacor, Inc. | 64,730,000 | -14,100,000 | 0 | 0.00 | 0.74 | 4.57 | - | - | 0.82 | 0.00 | -21.00% | -16.50% |
| Replimune Group, Inc. | 889,150,000 | -107,800,000 | 0 | 0.00 | 2.22 | 8.75 | - | - | 2.12 | 0.06 | -23.00% | -21.00% |
| REGENXBIO Inc. | 1,320,000,000 | 127,800,000 | 470,300,000 | 13.88 | 1.64 | 10.16 | - | - | 2.89 | 0.00 | 22.40% | 14.10% |
| Relay Therapeutics, Inc. | 3,440,000,000 | -363,900,000 | 3,000,000 | 0.00 | 3.38 | 8.23 | - | - | 3.59 | 0.00 | -51.60% | -46.00% |
| Rubius Therapeutics, Inc. | 204,150,000 | -196,500,000 | 0 | 0.00 | 0.94 | 2.07 | - | - | 0.90 | 0.00 | -81.20% | -52.20% |
| Revolution Medicines, Inc. | 1,820,000,000 | -187,100,000 | 29,400,000 | 0.00 | 2.73 | 7.05 | - | - | 3.16 | 0.00 | -28.30% | -24.50% |
| Recursion Pharmaceuticals, Inc. | 1,240,000,000 | -186,500,000 | 10,200,000 | 0.00 | 2.11 | 2.82 | - | - | 2.40 | 0.00 | -48.10% | -33.30% |
| SAB Biotherapeutics, Inc. | 124,700,000 | -17,100,000 | 60,900,000 | 10.19 | 2.96 | 0.71 | - | - | 3.76 | 0.10 | -18.90% | -15.90% |
| Sana Biotechnology, Inc. | 1,650,000,000 | -355,900,000 | 0 | 0.00 | 2.03 | 2.69 | - | - | 2.99 | 0.00 | -42.50% | -28.90% |
| Seagen Inc. | 26,520,000,000 | -674,500,000 | 1,570,000,000 | 0.00 | 8.28 | 11.28 | - | - | 12.28 | 0.00 | -20.70% | -17.30% |
| Sangamo Therapeutics, Inc. | 768,690,000 | -178,300,000 | 110,700,000 | 0.00 | 1.87 | 2.37 | - | - | 2.04 | 0.00 | -42.00% | -22.20% |
| SQZ Biotechnologies Company | 96,980,000 | -68,700,000 | 27,100,000 | 0.00 | 0.71 | 0.00 | - | - | 0.00 | 0.00 | -47.50% | -28.30% |
| Sorrento Therapeutics, Inc. | 633,390,000 | -428,300,000 | 52,900,000 | 0.00 | 7.04 | 0.35 | - | - | 4.99 | 1.81 | -272.90% | -60.30% |
| Scholar Rock Holding Corporation | 343,570,000 | -131,800,000 | 18,800,000 | 0.00 | 1.92 | 6.56 | - | - | 1.36 | 0.29 | -64.60% | -40.70% |
| Surrozen, Inc. | 129,020,000 | -54,600,000 | 0 | 0.00 | 0.95 | 2.36 | - | - | 1.27 | 0.00 | - | - |
| Sutro Biopharma, Inc. | 352,090,000 | -105,500,000 | 61,900,000 | 0.00 | 1.36 | 4.16 | - | - | 1.78 | 0.10 | -36.70% | -29.50% |
| Surface Oncology, Inc. | 108,750,000 | -78,500,000 | 2,700,000 | 0.00 | 0.80 | 2.92 | - | - | 0.71 | 0.00 | -56.30% | -39.30% |
| SpringWorks Therapeutics, Inc. | 2,460,000,000 | -173,900,000 | 0 | 0.00 | 5.47 | 7.19 | - | - | 6.59 | 0.00 | -36.20% | -34.40% |
| Talaris Therapeutics, Inc. | 353,470,000 | -47,800,000 | 0 | 0.00 | 1.19 | 4.82 | - | - | 1.45 | 0.00 | -26.60% | -20.60% |
| Protara Therapeutics, Inc. | 49,350,000 | -47,300,000 | 0 | 0.00 | 0.30 | 7.97 | - | - | 0.54 | 0.00 | -27.00% | -25.70% |
| Tarsus Pharmaceuticals, Inc. | 405,830,000 | -13,800,000 | 57,000,000 | 0.00 | 2.37 | 8.08 | - | - | 2.36 | 0.00 | -7.70% | -7.20% |
| TRACON Pharmaceuticals, Inc. | 48,290,000 | -28,700,000 | 300,000 | 0.00 | 3.67 | 1.10 | - | - | 2.00 | 0.12 | -182.40% | -97.30% |
| TCR2 Therapeutics Inc. | 91,770,000 | -99,800,000 | 0 | 0.00 | 0.33 | 6.97 | - | - | 0.35 | 0.00 | -31.50% | -27.80% |
| TScan Therapeutics, Inc. | 59,380,000 | -48,600,000 | 10,100,000 | 0.00 | 0.35 | 6.39 | - | - | 0.37 | 0.00 | -86.50% | -29.30% |
| Bio-Techne Corporation | 16,600,000,000 | 210,400,000 | 1,030,000,000 | 78.23 | 9.25 | 6.74 | 1.28 | 0.32% | 59.51 | 0.17 | 13.10% | 9.40% |
| Instil Bio, Inc. | 1,150,000,000 | -156,800,000 | 0 | 0.00 | 1.95 | 3.31 | - | - | 2.54 | 0.00 | -25.50% | -23.90% |
| Tenaya Therapeutics, Inc. | 457,820,000 | -72,700,000 | 0 | 0.00 | 1.57 | 5.77 | - | - | 1.82 | 0.00 | -76.60% | -30.20% |
| Titan Pharmaceuticals, Inc. | 9,140,000 | -8,800,000 | 1,500,000 | 0.00 | 1.42 | 0.48 | - | - | 1.52 | 0.00 | -111.90% | -81.70% |
| Valneva SE American Depositary Shares | 1,490,000,000 | 0 | 109,920,000 | 0.00 | 18.37 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Vericel Corporation | 1,780,000,000 | -7,500,000 | 156,200,000 | 0.00 | 9.44 | 2.00 | - | - | 17.20 | 0.00 | -4.80% | -3.30% |
| Vir Biotechnology, Inc. | 3,240,000,000 | 528,600,000 | 1,100,000,000 | 5.86 | 2.10 | 5.01 | - | - | 4.57 | 0.00 | 57.20% | 39.50% |
| Vaxart, Inc. | 579,660,000 | -70,500,000 | 900,000 | 0.00 | 2.66 | 1.14 | - | - | 3.48 | 0.00 | -36.70% | -31.40% |
| Voyager Therapeutics, Inc. | 401,590,000 | -71,200,000 | 37,400,000 | 0.00 | 3.11 | 2.58 | - | - | 3.03 | 0.00 | -66.30% | -34.50% |
| Windtree Therapeutics, Inc. | 27,930,000 | -67,600,000 | 0 | 0.00 | 0.52 | 0.62 | - | - | 1.25 | 0.37 | -112.60% | -70.00% |
| X4 Pharmaceuticals, Inc. | 46,470,000 | -102,600,000 | 0 | 0.00 | 0.62 | 2.41 | - | - | 0.57 | 0.53 | -124.70% | -76.00% |